Hypothermia Plus Melatonin in Asphyctic Newborns: A Randomized-Controlled Pilot Study
Conclusions:
The early addition of IV melatonin to asphyctic neonates is feasible and may improve long-term neurodevelopment. To our knowledge, this is the first clinical trial to analyze the administration of IV melatonin as an adjuvant therapy to therapeutic hypothermia.
Source: Pediatric Critical Care Medicine - Category: Pediatrics Tags: Neonatal Intensive Care Source Type: research
More News: Brain | Clinical Trials | Hypothermia | Intensive Care | Laboratory Medicine | Melatonin | Neurology | Pediatrics | Perinatology & Neonatology | Statistics | Study